2026 NPPES data Physician Assistant NPI 1285834820 RPA-C
Verify on CMS →

ENBAL BARAM, RPA-C

Physician Assistant in BABYLON, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
7K
Medicare Part D claims · 873 beneficiaries · Physician Assistant avg: 790
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$173.24
9 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ENBAL BARAM, RPA-C is a Physician Assistant ([object Object]) practicing in BABYLON, New York with a Medicare Part D prescribing footprint of 7K claims across 873 beneficiaries — 12% brand-name prescribing . Industry payments of $173.24 across 9 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ENBAL BARAM, RPA-C filed 6,551 Medicare Part D claims in 2023 across BABYLON, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ENBAL BARAM, RPA-C at a glance

Quality data not reported

NPI registry status

Active

Issued 07/23/2007

NPI 1285834820

Primary specialty

Physician Assistant

High-volume

149,975 US NPIs in this specialty

Medicare Part D claims

6,551 729% vs specialty avg

2023 prescription claims

Specialty avg: 790

Specialty distribution in New York

How Physician Assistant compares to other specialties among New York providers

New York providers

Physician Assistant share within New York

1. Physician Assistant42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Physician Assistant share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Physician Assistant (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Physician Assistant ABMS/AOA estimate

Est. board-certified rate (Physician Assistant) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Physician Assistant) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ENBAL BARAM, RPA-C is a Physician Assistant provider practicing in BABYLON, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: RPA-C. NPI: 1285834820. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ENBAL BARAM, RPA-C appears in the CMS NPPES registry as a Physician Assistant provider holding RPA-C credentials at 350 W MAIN ST, BABYLON, NY, 11702, with a listed phone of (631) 661-2277. NPI 1285834820 was issued on 07/23/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARAM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 6,551 prescription claims written by this provider, covering 873 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 0.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

350 W MAIN ST
BABYLON, NY 11702

Provider Details

NPI 1285834820
Specialty Physician Assistant
Credentials RPA-C
Gender Female
NPI Issued 07/23/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ENBAL BARAM, RPA-C. Source: openpaymentsdata.cms.gov.

Total received

$173

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ENBAL BARAM, RPA-C. To verify ENBAL BARAM, RPA-C's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ENBAL BARAM, RPA-C — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 6,551 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

6,551
Total Claims
$1.0M
Total Drug Cost
873
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
16,423
Total Day Supply
481,398
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$867K
Generic Drug Cost
$136K
Opioid Claims
36 (0.5% rate)
Antibiotic Claims
202

Patient Demographics

Average Patient Age
75.0 years
Avg HCC Risk Score
1.12
Gender Split
58% female / 42% male
Age Distribution
<65: 64, 65-74: 362, 75-84: 314, 85+: 133

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
340
Amlodipine Besylate
296
Levothyroxine Sodium
287
Metoprolol Succinate
287
Rosuvastatin Calcium
231
Metformin Hcl
155
Losartan Potassium
154
Montelukast Sodium
139
Simvastatin
136
Clopidogrel
Clopidogrel Bisulfate
119

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Physician Assistant Overview

How ENBAL BARAM, RPA-C fits within the Physician Assistant landscape nationally.

149,975
Physician Assistant Providers in US
56
States with Physician Assistant
790
Avg Claims per Provider

ENBAL BARAM, RPA-C's 6,551 claims are above the specialty average of 790.

Nearby Physician Assistant Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BARAM.

Compare Physician Assistant nationally: see state-by-state distribution →

Frequently Asked Questions

What is ENBAL BARAM, RPA-C's specialty?
ENBAL BARAM, RPA-C specializes in Physician Assistant and practices in BABYLON, New York. Credentials: RPA-C.
How much does ENBAL BARAM, RPA-C prescribe under Medicare Part D?
In 2023, ENBAL BARAM, RPA-C wrote 6,551 Medicare Part D claims totaling $1.0M in drug costs for 873 beneficiaries.
Where is ENBAL BARAM, RPA-C located?
ENBAL BARAM, RPA-C is located at 350 W MAIN ST, BABYLON, NY, 11702. Phone: (631) 661-2277.
What is ENBAL BARAM, RPA-C's NPI number?
ENBAL BARAM, RPA-C's National Provider Identifier (NPI) is 1285834820, issued on 07/23/2007.
Does ENBAL BARAM, RPA-C prescribe more brand-name or generic drugs?
ENBAL BARAM, RPA-C's prescribing is 12% brand-name and 88% generic drugs by claim count, with $867K in brand drug costs.
Does ENBAL BARAM, RPA-C prescribe opioids?
Yes, ENBAL BARAM, RPA-C had 36 opioid claims in 2023 with an opioid prescribing rate of 0.5%.
How many Physician Assistant providers are there in the US?
There are 149,975 Physician Assistant providers across 56 states in the US. The average Physician Assistant provider writes 790 Medicare Part D claims per year.
What drugs does ENBAL BARAM, RPA-C prescribe most often?
Based on 2023 Medicare Part D data, ENBAL BARAM, RPA-C's most frequently prescribed drugs include Atorvastatin Calcium, Amlodipine Besylate, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ENBAL BARAM, RPA-C accept Medicare?
ENBAL BARAM, RPA-C appears in CMS Medicare data with 6,551 Part D claims and 873 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ENBAL BARAM, RPA-C's credentials?
ENBAL BARAM, RPA-C's NPI is 1285834820 with credentials RPA-C. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology